The delivery device known as the 'pretzel' (courtesy J&J)
J&J reports latest data on Balversa-based ‘pretzel’ therapy for bladder cancer
Bladder cancer patients with a common mutation saw promising early results after receiving a Johnson & Johnson targeted therapy that administers the drug sold as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.